HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 65 filers reported holding HERON THERAPEUTICS INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $31,424 | -48.2% | 30,509 | -41.6% | 0.00% | – |
Q2 2023 | $60,650 | +30.2% | 52,284 | +69.5% | 0.00% | – |
Q1 2023 | $46,590 | +86.8% | 30,854 | +209.3% | 0.00% | – |
Q4 2022 | $24,943 | -57.0% | 9,977 | -27.4% | 0.00% | – |
Q3 2022 | $58,000 | -54.7% | 13,749 | -70.0% | 0.00% | – |
Q2 2022 | $128,000 | -77.9% | 45,838 | -54.7% | 0.00% | – |
Q1 2022 | $579,000 | -39.1% | 101,087 | -2.9% | 0.00% | – |
Q4 2021 | $951,000 | -47.4% | 104,112 | -38.4% | 0.00% | – |
Q3 2021 | $1,809,000 | -30.0% | 169,089 | +1.5% | 0.00% | -100.0% |
Q2 2021 | $2,585,000 | +43.9% | 166,543 | +50.2% | 0.00% | – |
Q1 2021 | $1,797,000 | -59.5% | 110,909 | -47.1% | 0.00% | -100.0% |
Q4 2020 | $4,440,000 | +35.4% | 209,801 | -5.2% | 0.00% | 0.0% |
Q3 2020 | $3,280,000 | -16.5% | 221,325 | -17.1% | 0.00% | 0.0% |
Q2 2020 | $3,928,000 | +372.7% | 267,008 | +277.3% | 0.00% | – |
Q1 2020 | $831,000 | -31.8% | 70,774 | +36.5% | 0.00% | – |
Q4 2019 | $1,219,000 | +2.4% | 51,863 | -19.4% | 0.00% | – |
Q3 2019 | $1,190,000 | -23.5% | 64,314 | -23.1% | 0.00% | – |
Q2 2019 | $1,555,000 | -83.3% | 83,613 | -78.0% | 0.00% | -100.0% |
Q1 2019 | $9,297,000 | -20.0% | 380,406 | -15.1% | 0.00% | -25.0% |
Q4 2018 | $11,619,000 | -19.2% | 447,930 | -1.5% | 0.00% | 0.0% |
Q3 2018 | $14,388,000 | +39.3% | 454,590 | +71.0% | 0.00% | +33.3% |
Q2 2018 | $10,329,000 | +518.5% | 265,847 | +339.1% | 0.00% | – |
Q1 2018 | $1,670,000 | +184.5% | 60,545 | +86.6% | 0.00% | – |
Q4 2017 | $587,000 | -72.1% | 32,450 | -75.1% | 0.00% | -100.0% |
Q3 2017 | $2,106,000 | +252.8% | 130,374 | +202.1% | 0.00% | – |
Q2 2017 | $597,000 | +0.3% | 43,162 | +9.1% | 0.00% | – |
Q1 2017 | $595,000 | +105.2% | 39,579 | +78.8% | 0.00% | – |
Q4 2016 | $290,000 | +51.0% | 22,137 | +98.2% | 0.00% | – |
Q3 2016 | $192,000 | +14.3% | 11,167 | +20.0% | 0.00% | – |
Q2 2016 | $168,000 | -22.6% | 9,309 | -18.4% | 0.00% | – |
Q1 2016 | $217,000 | +3.3% | 11,409 | +45.3% | 0.00% | – |
Q4 2015 | $210,000 | -60.2% | 7,854 | -63.7% | 0.00% | – |
Q3 2015 | $528,000 | +132.6% | 21,652 | +196.7% | 0.00% | – |
Q2 2015 | $227,000 | +530.6% | 7,298 | +180.3% | 0.00% | – |
Q1 2015 | $36,000 | +200.0% | 2,604 | +120.7% | 0.00% | – |
Q4 2014 | $12,000 | +20.0% | 1,180 | +0.7% | 0.00% | – |
Q3 2014 | $10,000 | -44.4% | 1,172 | -21.0% | 0.00% | – |
Q2 2014 | $18,000 | +1700.0% | 1,483 | +1383.0% | 0.00% | – |
Q1 2014 | $1,000 | – | 100 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TANG KEVIN C | 760 | $783 | 100.00% |
Velan Capital Investment Management LP | 6,986,744 | $7,196,346 | 5.80% |
Tejara Capital Ltd | 2,109,681 | $2,172,971 | 1.23% |
JW Asset Management, LLC | 2,407,418 | $2,479,641 | 1.07% |
Rubric Capital Management LP | 26,713,503 | $27,514,908 | 1.03% |
GREAT POINT PARTNERS LLC | 4,737,368 | $4,879,489 | 0.89% |
Orchard Capital Management, LLC | 2,142,823 | $2,207,108 | 0.82% |
Clearline Capital LP | 6,149,842 | $6,334,338 | 0.54% |
CM Management, LLC | 450,000 | $463,500 | 0.49% |
JACOB ASSET MANAGEMENT OF NEW YORK LLC | 327,450 | $337,274 | 0.48% |